Abstract

A Framework for Evaluating Assays for Automation

Jeff Gunnarsson, Senior Electrical Engineer and Partner, Key Tech

Demonstrating a viable chip-based biotechnology or microfluidic assay in a laboratory can be an exciting milestone, but the path to automation and commercialization of that assay is always challenging. Learn how a systems approach to de-risking and development can help you understand the key tradeoffs and priorities throughout an automated assay development program. Jeff Gunnarsson will discuss how to evaluate an assay based on various factors like environmental sensitivity, technical risks, and ease of use considerations—all while sticking to a focused product strategy—to compress development time from R&D to product launch.